Literature DB >> 26160695

Sensorimotor Cortex Injection of Adeno-Associated Viral Vector Mediates Knockout of PTEN in Neurons of the Brain and Spinal Cord of Mice.

Ping Yang1, Yu Qin2, Wen Zhang2, Zhiqun Bian2, Ruiqi Wang2.   

Abstract

Cre/loxP-mediated inactivation of phosphatase and tensin homolog (PTEN) is proposed to be a promising therapeutic agent for promoting CNS and PNS regeneration. And adeno-associated virus (AAV) vector has been developed as an attractive gene delivery system with proven safety. In the present study, we investigated Cre/loxP-mediated knockout of PTEN in the sensorimotor cortex, hippocampus, and spinal cord in PTEN floxed mice by immunohistological analysis of PI3K/AKT/mTOR expression in neurons of the sensorimotor cortex, hippocampus, and spinal cord after sensorimotor cortex injection of AAV-Cre. Two weeks after injection of AAV-Cre, the sensorimotor cortex, hippocampus, and spinal cord were dissected and examined the expression of downstream molecules pAKT and pS6 of PI3K/AKT signaling pathway. The results showed that remote delivery of AAV-Cre through sensorimotor cortex injection mediated PTEN knockout in neurons of the sensorimotor cortex, hippocampus, and spinal cord. We propose sensorimotor cortex injection of AAV may provide a potential strategy of gene therapy for the CNS diseases.

Entities:  

Keywords:  Adeno-associated virus (AAV); Axonal transport; Gene therapy; Hippocampus; Sensorimotor cortex; Spinal cord

Mesh:

Substances:

Year:  2015        PMID: 26160695     DOI: 10.1007/s12031-015-0610-x

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  35 in total

1.  Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene.

Authors:  Ralf Lesche; Matthias Groszer; Jing Gao; Ying Wang; Albee Messing; Hong Sun; Xin Liu; Hong Wu
Journal:  Genesis       Date:  2002-02       Impact factor: 2.487

Review 2.  RNA-based therapeutics: current progress and future prospects.

Authors:  John C Burnett; John J Rossi
Journal:  Chem Biol       Date:  2012-01-27

3.  CERE-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer's disease.

Authors:  Ronald J Mandel
Journal:  Curr Opin Mol Ther       Date:  2010-04

Review 4.  Recombinant adeno-associated viral vectors in the nervous system.

Authors:  Corinna Burger; Kevin Nash; Ronald J Mandel
Journal:  Hum Gene Ther       Date:  2005-07       Impact factor: 5.695

Review 5.  Gene therapy and neurodevelopmental disorders.

Authors:  Steven James Gray
Journal:  Neuropharmacology       Date:  2012-06-27       Impact factor: 5.250

6.  SOCS3 deletion promotes optic nerve regeneration in vivo.

Authors:  Patrice D Smith; Fang Sun; Kevin Kyungsuk Park; Bin Cai; Chen Wang; Kenichiro Kuwako; Irene Martinez-Carrasco; Lauren Connolly; Zhigang He
Journal:  Neuron       Date:  2009-12-10       Impact factor: 17.173

7.  Safety and tolerability of putaminal AADC gene therapy for Parkinson disease.

Authors:  C W Christine; P A Starr; P S Larson; J L Eberling; W J Jagust; R A Hawkins; H F VanBrocklin; J F Wright; K S Bankiewicz; M J Aminoff
Journal:  Neurology       Date:  2009-10-14       Impact factor: 9.910

Review 8.  Adeno-associated virus (AAV) gene therapy for neurological disease.

Authors:  Marc S Weinberg; R Jude Samulski; Thomas J McCown
Journal:  Neuropharmacology       Date:  2012-03-17       Impact factor: 5.250

9.  A rapid and scalable system for studying gene function in mice using conditional RNA interference.

Authors:  Prem K Premsrirut; Lukas E Dow; Sang Yong Kim; Matthew Camiolo; Colin D Malone; Cornelius Miething; Claudio Scuoppo; Johannes Zuber; Ross A Dickins; Scott C Kogan; Kenneth R Shroyer; Raffaella Sordella; Gregory J Hannon; Scott W Lowe
Journal:  Cell       Date:  2011-04-01       Impact factor: 41.582

Review 10.  Neurotrophins and spinal circuit function.

Authors:  Vanessa S Boyce; Lorne M Mendell
Journal:  Front Neural Circuits       Date:  2014-06-05       Impact factor: 3.492

View more
  2 in total

1.  Conditional Depletion of Hippocampal Brain-Derived Neurotrophic Factor Exacerbates Neuropathology in a Mouse Model of Alzheimer's Disease.

Authors:  David J Braun; Sergey Kalinin; Douglas L Feinstein
Journal:  ASN Neuro       Date:  2017 Mar-Apr       Impact factor: 4.146

2.  Cortical AAV-CNTF Gene Therapy Combined with Intraspinal Mesenchymal Precursor Cell Transplantation Promotes Functional and Morphological Outcomes after Spinal Cord Injury in Adult Rats.

Authors:  Stuart I Hodgetts; Jun Han Yoon; Alysia Fogliani; Emmanuel A Akinpelu; Danii Baron-Heeris; Imke G J Houwers; Lachlan P G Wheeler; Bernadette T Majda; Sreya Santhakumar; Sarah J Lovett; Emma Duce; Margaret A Pollett; Tylie M Wiseman; Brooke Fehily; Alan R Harvey
Journal:  Neural Plast       Date:  2018-08-06       Impact factor: 3.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.